HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Pulmonary Heart Diseases
Pulmonary Heart Diseases
Chronic lung conditions such as chronic obstructive pulmonary disease (COPD) and pulmonary hypertension can lead to a serious condition known as pulmonary heart diseases. When the blood vessels in the lungs become damaged or narrowed, the right side of the heart faces increased pressure, leading to strain and enlargement of the heart’s right ventricle. Over time, this can result in right heart failure. Pulmonary heart diseases often go unnoticed in the early stages, but with appropriate treatment, such as oxygen therapy, medications to reduce lung pressures, and lifestyle modifications, patients can manage their condition effectively. Addressing the root cause—often the underlying lung disease—remains crucial in improving outcomes.
Committee Members
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain